SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-000817
Filing Date
2024-05-14
Accepted
2024-05-14 16:46:11
Documents
85
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q derm-20240331x10q.htm   iXBRL 10-Q 1269906
2 EX-31.1 derm-20240331xex31d1.htm EX-31.1 13207
3 EX-31.2 derm-20240331xex31d2.htm EX-31.2 13902
4 EX-32.1 derm-20240331xex32d1.htm EX-32.1 6558
5 EX-32.2 derm-20240331xex32d2.htm EX-32.2 7409
  Complete submission text file 0001410578-24-000817.txt   6495091

Data Files

Seq Description Document Type Size
6 EX-101.SCH derm-20240331.xsd EX-101.SCH 56791
7 EX-101.CAL derm-20240331_cal.xml EX-101.CAL 62410
8 EX-101.DEF derm-20240331_def.xml EX-101.DEF 228764
9 EX-101.LAB derm-20240331_lab.xml EX-101.LAB 485250
10 EX-101.PRE derm-20240331_pre.xml EX-101.PRE 369464
89 EXTRACTED XBRL INSTANCE DOCUMENT derm-20240331x10q_htm.xml XML 983648
Mailing Address 9237 E VIA DE VENTURA BLVD., SUITE 105 SCOTTSDALE AZ 85258
Business Address 9237 E VIA DE VENTURA BLVD., SUITE 105 SCOTTSDALE AZ 85258 480-434-6670
Journey Medical Corp (Filer) CIK: 0001867066 (see all company filings)

IRS No.: 471879539 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41063 | Film No.: 24945256
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)